IL-12 deficiency transiently improves viral clearance during the late phase of respiratory tract infection with influenza A virus in mice

被引:11
|
作者
van der Sluijs, Koenraad F.
van Elden, Leontine J. R.
Xiao, Yanling
Arens, Ramon
Nijhuis, Monique
Schuurman, Rob
Florquin, Sandrine
Jansen, Henk M.
Lutter, Rene
van der Poll, Tom
机构
[1] Univ Amsterdam, Acad Med Ctr, Expt Immunol Lab, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Utrecht, Eijkman Winkler Inst, Dept Virol, Med Ctr, Utrecht, Netherlands
[5] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
关键词
influenza; pneumonia; interleukin-12; innate response;
D O I
10.1016/j.antiviral.2006.01.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
T helper 1-driven immune responses have been implicated in protective immunity against viral infections. Interleukin (IL)-12 is a heterodimeric proinflammatory cytokine formed by a p35 and a p40 Subunit that can induce differentiation of naive T cells towards a T helper 1-response. To determine the role of IL-12 in respiratory tract infection with influenza, p35 gene deficient (p35(-/-)) and normal wild type mice were intranasally infected with influenza A virus. IL-12 p35(-/-) mice displayed a transiently enhanced rather than an impaired viral clearance, as indicated by a 10-fold reduction in viral loads on day 8 after infection. Although interferon-gamma levels were significantly lower in the lungs of IL-12 p35(-/-) mice, their cellular immune responses were not altered, as reflected by similar T cell CD69 expression and influenza-specific T cell recruitment. Our data indicate that endogenous IL-12 impairs viral clearance during the late phase of influenza A virus infection in mice. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 84
页数:10
相关论文
共 50 条
  • [1] Differential effect of IL-23 and IL-12 treatment during influenza A virus infection
    Dimitriou, ID
    Petrovas, C
    Mueller, YM
    Katsikis, PD
    FASEB JOURNAL, 2004, 18 (04): : A92 - A92
  • [2] The Protective Effects of Intranasal Administration of IL-12 Given Before Influenza Virus Infection and the Negative Effects of IL-12 Treatment Given After Viral Infection
    Ishikawa, Hiroki
    Ino, Satoshi
    Sasaki, Hiraku
    Fukui, Toshie
    Kohda, Chikara
    Tanaka, Kazuo
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (09) : 1487 - 1496
  • [3] Interleukin 12 is a primary cytokine responding to influenza virus infection in the respiratory tract of mice
    Hama, Y.
    Kurokawa, M.
    Imakita, M.
    Yoshida, Y.
    Shimizu, I.
    Watanabe, W.
    Shiraki, K.
    ACTA VIROLOGICA, 2009, 53 (04) : 233 - 240
  • [4] INFECTION OF THE UPPER RESPIRATORY TRACT OF MICE WITH INFLUENZA-A VIRUS
    IIDA, T
    BANG, FB
    AMERICAN JOURNAL OF HYGIENE, 1963, 77 (02): : 169 - 176
  • [5] The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice
    Tate, Michelle D.
    Brooks, Andrew G.
    Reading, Patrick C.
    RESPIRATORY RESEARCH, 2008, 9 (1)
  • [6] The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice
    Michelle D Tate
    Andrew G Brooks
    Patrick C Reading
    Respiratory Research, 9
  • [7] Antiviral effect of eosinophils in respiratory tract infection with influenza virus in mice
    Suzanne M Bal
    Annemiek Dijkhuis
    Koen van der Sluijs
    Rene Lutter
    Journal of Inflammation, 10 (Suppl 1)
  • [8] Topography of respiratory tract and gut microbiota in mice with influenza A virus infection
    Chen, Qichao
    Liu, Manjiao
    Lin, Yanfeng
    Wang, Kaiying
    Li, Jinhui
    Li, Peihan
    Yang, Lang
    Jia, Leili
    Zhang, Bei
    Guo, Hao
    Li, Peng
    Song, Hongbin
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [9] Mice lacking IL-12 develop polarized Th1 cells during viral infection
    Schijns, VECJ
    Haagmans, BL
    Wierda, CMH
    Kruithof, B
    Heijnen, IAFM
    Alber, G
    Horzinek, MC
    JOURNAL OF IMMUNOLOGY, 1998, 160 (08): : 3958 - 3964
  • [10] The effect of IL-12 treatment on vaccine-enhanced illness during infection with respiratory syncytial virus
    Openshaw, PJ
    Hussell, T
    MODULATION OF THE IMMUNE RESPONSE TO VACCINE ANTIGENS, 1998, 92 : 179 - 185